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Abstract
Background: Visceral leishmaniasis (VL) is a major public health problem in Bangladesh with the highest disease
burden in the Mymensingh District. The disease is transmitted by sand fly bites, but it may also be transmitted
through blood transfusions. No information is available about the prevalence of Leishmania infection among blood
donors in Bangladesh; therefore we aimed to investigate this question.
Methods: The study was carried out in the Blood Transfusion Department of Mymensingh Medical College
Hospital. One thousand one hundred and ninety five adult healthy blood donors attending in this department
were enrolled in the study from August 2010 to April 2011. After obtaining written consent, socio-demographic
data and a detailed health history were collected. The medical officer in the unit performed a complete physical
examination to exclude any acute or chronic diseases, which was followed by sero-diagnosis for exposure to
Leishmania by rK39 strip test using finger prick blood. Blood donors with a positive rK39 strip test underwent a PCR
test for detection of leishmania DNA in their peripheral blood buffy coat.
Results: Eighty two percent of enrolled blood donors were male (n=985) and 18% (n=210) were female. The mean
age of blood donors was 27 years (SD, 7.95 years). The majority of donors were literate and had mid-to-higher
socioeconomic condition reflected by household conditions reported by the subject. Only 2.6% had a family
member with VL in the past. Three blood donors were positive for leishmania infection by rK39 strip test (0.3%,
95%CI, 0.05%-0.73%). None of these 3 had active leishmania infection as demonstrated by PCR analysis. During six
months of follow up, neither rK39 positive (n=3) nor rK39 negative (n=1192) donors developed VL.
Conclusion: The prevalence of Leishmania donovani infection among blood donors attending the Blood
Transfusion Department of Mymensingh Medical College Hospital was very low. Therefore the chance for
transmission of VL through blood transfusion is negligible. We believe that the National VL Elimination Program
does not need set up routine screening for Leishmania donovani infection in blood transfusion departments located
in VL endemic areas of Bangladesh.
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Background
Human visceral leishmaniasis (VL) / kala-azar (KA) is a se-
vere chronic disease caused by parasites of the Leishmania
donovani complex. The disease is lethal if left untreated
and affects approximately half a million new patients
annually worldwide, with 60% of new cases on the
Indian sub-continent [1]. The disease is highly clustered
geographically, and Mymensingh District is the most
highly-endemic district out of 45 affected districts in
Bangladesh [2,3]. Leishmania donovani is the only species
that causes VL on the Indian sub-continent, including
Bangladesh. The female sand fly Phlebotomus argentipes is
only vector responsible for transmitting the disease in this
region, and humans are the only reservoir [1-3]. Recent
advances in leishmaniasis research have lead to the disco-
very of a very simple way to diagnose VL using an immu-
nochromatographic test (ICT), which detects antibody
against the rK39 antigen of the Leishmania parasite, and
home-based treatment of VL is now possible with the oral
drug Miltefosine. The unique epidemiologic characteris-
tics of VL on the Indian sub-continent, along with these
recent advances in diagnosis and treatment, make it pos-
sible to control or even eliminate this disease [4]. These
facts inspired the Health Ministers from Bangladesh, India
and Nepal to sign a Memorandum of Understanding in
2005 to eliminate VL from the sub-continent by 2015 [5].
The goal of the elimination program was to reduce
VL cases below 1 per 10,000 people in the VL en-
demic areas [5] through 1) active case detection and
proper management of cases with VL and Post-Kala-azar
Dermal Leishmaniasis (PKDL); 2) interruption of disease
transmission through integrated vector management
strategies; and 3) social mobilization [4,5].
Recent literature has suggested that VL disease may be
transmitted through blood transfusions if blood donors
have active infection with the leishmania parasite. The first
reported transmission of VL through blood transfusion
was documented in 1948 [6], and since then there has been
increasing evidence of transfusion-transmitted VL in VL
endemic countries [7-13]. No information is available
about VL transmission through blood transfusion in
Bangladesh. Mymensingh is the most highly-endemic
district for VL in Bangladesh, where more than 50% of the
national burden of VL cases has been reported. The Blood
Transfusion Department of Mymensingh Medical College
Hospital is the only public blood transfusion unit in the
district, serving patients of the medical college and those
referred by 12 sub-district hospitals in Mymensingh. Usu-
ally, blood donors attending this department are relatives
of patients who require blood transfusions. Since VL is
clustered at the household and village level, theoretically
there is a risk of VL transmission through blood transfu-
sion if active Leishmania infection is found among blood
donors. This may necessitate the introduction of routine
screening for Leishmania infection among blood donors by
the National VL Elimination Program. We have therefore
undertaken this study to fill this knowledge gap in
Bangladesh to support the National VL Elimination
Program. Our study investigates the prevalence of
Leishmania infection among blood donors in VL endemic
areas of Bangladesh.
Methods
Study site and population
The study was carried out in the Blood Transfusion
Department, Mymensingh Medical College Hospital,
Mymensingh District from August 2010 to April 2011.
During the study period, voluntary blood donors attending
in the department were invited to participate in the study.
On each working day, up to 10 voluntary blood donors
were enrolled in the study after obtaining written informed
consent and passing screening based on study inclusion
and exclusion criteria. The study inclusion criteria were:
age between 18–60 years old; either sex; clinically healthy;
no history of VL in the past; permanent resident of
Mymensingh District; and voluntary consent to participate
in the study. Exclusion criteria were: age less than 18 years
old or more than 60 years old; clinical evidence of acute or
chronic illness; past history of Kala-azar or PKDL; presence
of PKDL-like skin lesions; and refusal to consent to
study participation.
Study design and sampling
The study design was a cross-sectional survey with 6
months follow up. A trained field research assistant
(FRA) consented prospective subjects and collected
socio-demographic information using a structured
questionnaire, then the medical officer of the transfusion
unit performed a clinical assessment and enrolled study
participants after checking inclusion and exclusion criteria.
The medical laboratory technician of the transfusion unit
performed the rK39 strip test (rK39 ICT, Kala-azar
DetectR, In Bios International, Seattle, USA) using finger
prick blood from the participants, as per the manufac-
turer’s instructions. If a study participant tested positive for
Leishmania infection by the rK39 strip test, then a lab tech-
nician collected 3 ml venous blood in an EDTA tube and
this was transported to the Parasitology Laboratory, icddr,b
maintaining cold chain for buffy coat preparation, DNA
isolation and Ln-PCR analysis (see laboratory methods).
All rK39 positive blood donors were regarded as not
eligible for blood donation. Since the median incubation
period for developing VL is approximately four months [2],
all study participants, including those with positive rK39
strip tests, were followed for six months for eventual deve-
lopment of VL using mobile phone contact or home visits
(when possible). All participants were instructed to contact
study staff if they developed a fever of more than two
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weeks, or experienced weight loss, skin darkening and/or
abdominal enlargement within six months of enrollment.
Laboratory methods
Preparation of buffy coat
Upon receipt at the laboratory, blood samples were centri-
fuged at 8000 rpm for 10 minutes at room temperature,
and 500 μL of buffy coat was collected from the middle
layer of the tube containing concentrated leukocytes. The
buffy coat was kept in a 1.5-mL sterile microcentrifuge
tube and preserved at −20°C for DNA extraction and
PCR amplification.
DNA extraction from buffy coat
Buffy coat DNA was extracted for PCR using a QIAamp
DNA blood mini kit (Qiagen, Hilden, Germany, Cat. no.
51106), as per the manufacturer’s instructions. The DNA
was eluted in 0.2 mL of AE buffer (supplied with the
Qiagen kit) after extraction. The purity of the DNA was
satisfactory since the OD ratio at A260/A280 was within
1.7-1.9 for all DNA samples. Molecular-grade water was
used instead of blood as an extraction control for chec-
king for carry-over contamination in every run of DNA
extraction and PCR amplification.
PCR analysis
Leishmania-specific nested PCR (Ln-PCR) was performed
to detect parasite DNA in peripheral buffy coat using
2 μL of extracted DNA by the method described pre-
viously [14], with primers targeting the parasite’s SSU-
rRNA region [15]. For the first PCR run, we used primers
R221 50-GGTTCCTTTCCTGATTTACG-30 and R332 50-
GGCCGGTAAAGGCCGAATAG-30. For the second PCR,
1 μL of 1:50 dilution of the first PCR product was used as
a template in the presence of 0.15 μmol/L of the
Leishmania-specific primers R223 and R333.
Sample size calculation
Seroprevalence by the rK39 strip test among individuals
without past VL infection is 6% in the highly endemic areas
of Mymensingh District, with 3% of seropositive individuals
having confirmed active leishmania parasite infection by
polymerase chain reaction (PCR) analysis (unpublished
data). Thus to demonstrate an active infection rate of 3%
among blood donors with 1% precision and 95% confidence
interval (CI), a minimum sample size of 1,117 blood donors
was required.
Data analysis
Socio-demographic data and laboratory results were
entered into EPI Info 3.5.1 software (CDC, Atlanta, GA)
for windows. After cleaning the data and checking for
duplicates we explored the descriptive statistics to interro-
gate the nature of the data. A 95%CI was calculated using
Normal as well as Poisson distributional approaches,
where applicable. We analyzed all data using the
statistical software STATA 10.1 (Stata Corporation,
College Station, Texas).
Ethical statement
Blood donors were enrolled in the study after obtaining
written consent. All rK39 positive blood donors were
informed of their status and advised not to donate blood
for the next six months. All rK39 positive blood donors
were then followed for six months to see if they developed
VL. The study was approved by the Research Review
Committee and Ethical Review Committee of icddr,b,
Dhaka, Bangladesh; and the WHO Regional Office for
South-East Asia, New Delhi, Inida. The study was also




During the study period, a total of 14,367 voluntary blood
donors attended the Blood Transfusion Department of
Mymensingh Medical College Hospital for blood donation.
Among them, 1,195 blood donors were enrolled in the
study. Approximately 82% of the blood donors were male
and the average (SD) age of the donors was 27.66 (7.95)
years. Fifty percent of enrollees reported donating blood at
least once per year. Almost all the donors were donating
blood for their relatives or friends, and more than 90%
were aware of Kala-azar (Table 1).
The majority of blood donors had mid-to-high socioeco-
nomic status, as reflected by household and living condi-
tions (non-precarious house 94.8%; average number of
rooms in the house 3.53). The majority of participants also
practiced protection against mosquito/sand fly bites with
83.4% reporting they used a bed-net the previous night.
The average family size was 5.7 members, and only 2.6% of
participants reported having a family member with VL in
the past (Table 1).
Prevalence of Leishmania infection among blood donors
We identified only 3 individuals out of 1,195 with posi-
tive rK39 strip tests, indicating that the prevalence of
Leishmania infection among these blood donors was 0.3%
(n=3, 95%CI, 0.05%-0.73%). None of the positive blood
donors were positive for Leishmania DNA in their
peripheral blood, indicating that none suffered from active
Leishmania infection (Table 2). One of the 3 positive blood
donors came from a previously VL-infected house-
hold. None of the 1,195 participants developed VL
during the 6 months follow-up period.
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Discussion
This is the first study to investigate the prevalence of
Leishmania infection among blood donors in Bangladesh,
and the major finding of the study is that the prevalence of
active Leishmania infection among blood donors in
Mymensingh District is very low. Our study results suggest
there is a negligible risk of transmission of Leishmania
infection through donated blood from healthy voluntary
blood donors in Mymensingh. This is a welcome news for
the National VL Elimination Program, because our study
would suggest that the introduction of routine screening
for Leishmania infection among blood donors in the VL
endemic districts of Bangladesh is unnecessary.
VL is well known as a disease of the poorest of the poor.
Therefore the low prevalence of Leishmania infection
among blood donors in our study may be attributable to
their higher socio-economic status, as demonstrated by
better housing conditions, the number of rooms and bed-
nets in the household and bed-net usage. It is also possible
that the prevalence rate found in our study was underesti-
mated due to the use of rapid (rK39) tests for detection of
Leishmania donovani infection. The use of the Direct
Agglutation Test (DAT) has been recommended for
detection of VL infection [16]; however, many studies
[17-19] have shown good correlation and agreement
between the DAT and the rK39 rapid test. Further,
the DAT test for detection of Leishmania infection is
no longer in use by the National Program in Bangladesh.
The National VL Elimination Guideline of Bangladesh
has recommended the rK39 strip test for detection of
Leishmania infection in the country. The fact that
none of the study participants who tested negative by
the rK39 rapid test developed VL during six months
of follow up indicates that the rK39 strip test did not
miss Leishmania infections in our study population.
The study findings can help a guide to the National
VL Elimination Program since it was carried out
in Mymensingh, the highest VL endemic district in
Bangladesh where the risk of VL transmission through
blood transfusion would be highest.
Conclusions
The risk for transmission of VL through donated blood
from healthy blood donor volunteers in Mymensingh is
very low. There is no strong justification for routine
screening for Leishmania infection among blood donors
in Bangladesh.
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Table 2 Serological analysis of blood from the blood
donors in Mymensingh Medical College Hospital,
Mymensingh
Serological test n (%)
rK39 test results; N=1195
– Positive 3 (0.3)
– Negative 1192 (99.7)
PCR test done; N=3 3 (100.0)
PCR results; N=3
– Positive 0 (0.0)
– Negative 3 (100.0)
Table 1 Characteristics of blood donors in Mymensingh
Medical College Hospital, Mymensingh (N=1195)
Characteristics n (%)
Sex
– Male 985 (82.4)
– Female 210 (17.6)
Mean Age in years (SD) 27.66 (7.95)
Education
– Illiterate 80 (6.7)
– Literate 1115 (93.3)
Occupation
– Own agriculture 77 (6.4)
– Skilled worker 43 (3.6)
– Unskilled worker 13 (1.1)
– Own business 256 (21.4)
– Job holder 246 (20.6)
– Student 432 (36.2)
– Housewife 117 (9.8)
– Others 11(0.9)
Donate blood at least once in a year 594 (49.7)
Reason for blood donation
– Relative or friend patient 1187 (99.4)
– Registered blood donor 7 (0.6)
Heard about Kala-azar 1128 (94.4)
House type of blood donor
– Precarious 62 (5.2)
– Non-precarious 1133 (94.8)
Mean no. of living room (SD) in the household 3.53 (1.61)
Average family size (SD) 5.7 (2.3)
Average number of bed-nets (SD) in the household 3.31 (1.41)
Use bed net previous night 997 (83.4)
Past KA patients in the household 31 (2.6)
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